204 related articles for article (PubMed ID: 11207312)
1. Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis.
Boirivant M; Fuss IJ; Ferroni L; De Pascale M; Strober W
J Immunol; 2001 Mar; 166(5):3522-32. PubMed ID: 11207312
[TBL] [Abstract][Full Text] [Related]
2. Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease.
Coccia EM; Remoli ME; Di Giacinto C; Del Zotto B; Giacomini E; Monteleone G; Boirivant M
Gut; 2005 Nov; 54(11):1558-64. PubMed ID: 16105891
[TBL] [Abstract][Full Text] [Related]
3. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.
Neurath MF; Fuss I; Kelsall BL; Presky DH; Waegell W; Strober W
J Exp Med; 1996 Jun; 183(6):2605-16. PubMed ID: 8676081
[TBL] [Abstract][Full Text] [Related]
4. Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation.
Kitani A; Fuss IJ; Nakamura K; Schwartz OM; Usui T; Strober W
J Exp Med; 2000 Jul; 192(1):41-52. PubMed ID: 10880525
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath MF; Fuss I; Kelsall BL; Stüber E; Strober W
J Exp Med; 1995 Nov; 182(5):1281-90. PubMed ID: 7595199
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis.
Fiorucci S; Distrutti E; Mencarelli A; Barbanti M; Palazzini E; Morelli A
Digestion; 2002; 66(4):246-56. PubMed ID: 12592101
[TBL] [Abstract][Full Text] [Related]
7. The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis.
Fuss IJ; Boirivant M; Lacy B; Strober W
J Immunol; 2002 Jan; 168(2):900-8. PubMed ID: 11777988
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice.
Tozawa K; Hanai H; Sugimoto K; Baba S; Sugimura H; Aoshi T; Uchijima M; Nagata T; Koide Y
J Gastroenterol Hepatol; 2003 May; 18(5):578-87. PubMed ID: 12702051
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation.
Strober W; Kelsall B; Fuss I; Marth T; Ludviksson B; Ehrhardt R; Neurath M
Immunol Today; 1997 Feb; 18(2):61-4. PubMed ID: 9057354
[TBL] [Abstract][Full Text] [Related]
11. Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.
Zuo L; Yuan KT; Yu L; Meng QH; Chung PC; Yang DH
World J Gastroenterol; 2014 Dec; 20(48):18316-29. PubMed ID: 25561798
[TBL] [Abstract][Full Text] [Related]
12. NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice.
Fiorucci S; Antonelli E; Distrutti E; Del Soldato P; Flower RJ; Clark MJ; Morelli A; Perretti M; Ignarro LJ
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15770-5. PubMed ID: 12427966
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
[TBL] [Abstract][Full Text] [Related]
15. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice.
Fuss IJ; Marth T; Neurath MF; Pearlstein GR; Jain A; Strober W
Gastroenterology; 1999 Nov; 117(5):1078-88. PubMed ID: 10535870
[TBL] [Abstract][Full Text] [Related]
16. An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo.
Stallmach A; Marth T; Weiss B; Wittig BM; Hombach A; Schmidt C; Neurath M; Zeitz M; Zeuzem S; Abken H
Gut; 2004 Mar; 53(3):339-45. PubMed ID: 14960512
[TBL] [Abstract][Full Text] [Related]
17. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
18. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis.
Fiorucci S; Mencarelli A; Palazzetti B; Distrutti E; Vergnolle N; Hollenberg MD; Wallace JL; Morelli A; Cirino G
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13936-41. PubMed ID: 11717450
[TBL] [Abstract][Full Text] [Related]
19. Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.
Guan Q; Ma Y; Hillman CL; Qing G; Ma AG; Weiss CR; Zhou G; Bai A; Warrington RJ; Bernstein CN; Peng Z
Mol Med; 2011; 17(7-8):646-56. PubMed ID: 21424108
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.
del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG
J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]